E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers T > Headlines for Teva Pharmaceutical Finance Netherlands II, BV > News item
Published on 3/24/2015 in the Prospect News Bank Loan Daily, Prospect News Convertibles Daily, Prospect News Emerging Markets Daily and Prospect News Investment Grade Daily.

S&P rates Teva notes A-

Standard & Poor's said it assigned its A- senior unsecured issue-level rating to Teva Pharmaceutical Finance Netherlands II BV's senior unsecured notes due 2025.

The notes are guaranteed by Teva Pharmaceutical Industries Ltd. (A-/stable/-).

The agency said it regards the transaction as leverage neutral because the company has retired roughly $1.3 billion of debt thus far in 2015 and has additional upcoming near-term maturities.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.